United States· US:16714-781_af904a13-cf99-4e52-8225-9074a05445a0
ezetimibe and simvastatin
A simvastatin and ezetimibe product containing ezetimibe; simvastatin, registered in United States by NORTHSTAR RX LLC. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Simvastatin and ezetimibe is registered in 13 of 19 countries.
Countries holding a registration under ATC C10BA02 (simvastatin and ezetimibe), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Simvastatin and ezetimibe · ATC C10BA02
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- EZETIMIBE; SIMVASTATIN
- Manufacturer
- NORTHSTAR RX LLC
- Country
- United States (US)
- ATC code
- C10BA02
- ATC class
- Simvastatin and ezetimibe
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1116714-781-01
- ndc1116714-781-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
14 interactions on record for simvastatin and ezetimibe.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Simvastatin and ezetimibe · interactions on record
14 records
14 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C10BA02
Simvastatin and ezetimibe, as other registers publish it.
- ItalyAMISITELAEBERLIFE FARMACEUTICI S.P.A.
- ItalyAMISITELAEBERLIFE FARMACEUTICI S.P.A.
- ItalyAMISITELAEBERLIFE FARMACEUTICI S.P.A.
- BelgiumEzesimteva 10 mg - 10 mgTeva Pharma Belgium
- BelgiumEzesimteva 10 mg - 20 mgTeva Pharma Belgium
- BelgiumEzesimteva 10 mg - 40 mgTeva Pharma Belgium
- BelgiumEzesimteva 10 mg - 80 mgTeva Pharma Belgium
- SwitzerlandEzetimib Simva Spirig HC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3076aae4-5a01-4347-ab8f-073645461ef5 GET /v1/drugs/3076aae4-5a01-4347-ab8f-073645461ef5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10; 80",
"substance": "EZETIMIBE; SIMVASTATIN",
"productndc": "16714-781",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA208699",
"marketing_category": "ANDA"
}See everything about simvastatin and ezetimibe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.